Abstract: A safety chain assembly 24 for securing a towed agricultural vehicle (not shown) to a towing vehicle 21. The safety chain assembly 24 includes a clevis hook 54 having two pin receiving openings 55; a latch member 60 having an attachment opening 62; a spring pin assembly 56, and an elongated load bearing device 36 having a securing opening 37. In the preferred embodiment shown in the drawings the elongated load bearing device 36 is a chain, but it will be appreciated that it could also be a wire rope or other load bearing device having a securing opening 37. Similarly, the preferred spring pin assembly 56 includes a biasing mechanism such as a spring 64 and a washer 66; a retention member 70 and a pin 72; the pin 72 having an annular groove 84, a head 85 and first and second ends 87, 89; the annular groove 84 being located proximate the first end 87 and the head 85 being located proximate the second end 89.

Abstract: Provided herein is a compound having the formula (I): Wherein said compounds are useful for the treatment of psychiatric disorders including but not limited to depression, generalized anxiety, eating disorders, dementia, panic disorder, and sleep disorders. The compounds may also be useful in the treatment of gastrointestinal disorders, cardiovascular regulation, motor disorders, endocrine disorders, vasospasm and sexual dysfunction. The compounds are 5HT1B and 5HT1D antagonists.

Abstract: Compounds having selective action at neuronal N-type calcium channels useful for the treatment of pain in accord with the following structural diagram, wherein R1, R2 and R3 are a variety of groups as defined in the specification.

Abstract: Compounds useful for the treatment of pain in accord with the following structural diagram, wherein R1, R2 and R3 are any of a number of groups as defined in the specification and pharmaceutical compositions and methods of treatment utilising such compounds.

Abstract: Compounds represented by Formula (I): (I)or pharmaceutically acceptable salts thereof, are effective as NMDA NR2B antagonists useful for relieving pain.

Abstract: Provided herein is a compound represented by the Formula (I) wherein said compounds are useful for the treatment of migraine. Also provided are processes for the preparation of compounds of Formula (I) and intermediates.

Abstract: Provided herein is a compound of the formula (I) wherein said compound is useful for the treatment of psychiatric disorders including but not limited to depression, generalized anxiety, eating, disorders, dementia, panic disorder, and sleep disorders. The compounds may also be useful in the treatment of gastrointestinal disorders, cardiovascular regulation, motor disorders, endocrine disorders, vasospasm and sexual dysfunction. The compounds are 5HT1B antagonists. Also provided herein are processes for making compounds of Formula (I) and intermediate compounds.

Abstract: Provided herein is a compound having the formula (I) wherein said compounds are useful for the treatment of psychiatric disorders including but not limited to depression, generalized anxiety, eating disorders, dementia, panic disorder, and sleep disorders. The compounds may also be useful in the treatment of gastrointestinal disorders, cardiovascular regulation, motor disorders, endocrine disorders, vasospasm and sexual dysfunction. The compounds are 5HT1B and 5HT1D antagonists.

Abstract: Compounds useful for the treatment of pain in accord with the following structural diagram, 1

Abstract: Compounds useful for the treatment of pain in accord with the following structural diagram, 1

Abstract: Compounds having selective action at neuronal N-type calcium channels useful for the treatment of pain in accord with the following structural diagram, 1

Abstract: Compounds useful for the treatment of pain in accord with the following structural diagram, 1

Abstract: Catalytic and/or adsorbent compositions are formed with greater flexibility to optimize various properties, such as strength and catalytic activity by employing a synthetic clay binder having a small particle size, e.g., an average particle size no greater than about 100 nm. Embodiments of the present invention comprise compositions containing a catalytic component and/or adsorbent component and laponite which functions as a binder either alone or with an additional binder component. Embodiments of the present invention further include a catalytic and/or adsorbent composition containing an inorganic binder and laponite as a lubricant to facilitate shaping, as by extrusion.

Abstract: Compounds represented by Formula (I): 1

Abstract: 4-substituted cyclohexanes substituted in the 1-position with imidazopyridine either directly or through a C1-C4alkyl, C1-C4alkenyl, C1-C4alkynyl, C1-C4alkoxy, amino, aminoC1-C4alkyl, hydroxyC1-C4alkyl, carbonyl, cycloC3-C6alkyl or aminocarbonyl chain are effective as NMDA NR2B antagonists useful for relieving pain.

Abstract: Compounds represented by Formula (I): 1

Abstract: Compounds described by the chemical structural formula or a pharmaceutically acceptable salt thereof, are useful in the treatment of pain, migraine, depression, anxiety, schizophrenia, Parkinson's disease, stroke, and in the treatment of neuropathies including postherpetic neuralgia, central pain from spinal cord injury, and phantom limb pain.

Abstract: 4-substituted cyclohexanes substituted in the 1-position with imidazopyridine either directly or through a C1-C4alkyl, C1-C4alkenyl, C1-C4alkynyl, C1-C4alkoxy, amino, aminoC1-C4alkyl, hydroxyC1-C4alkyl, carbonyl, cycloC3-C6alkyl or aminocarbonyl chain are effective as NMDA NR2B antagonists useful for relieving pain.

Abstract: 4-substituted cyclohexanes substituted in the 1-position with quinazoline either directly or through a C1-C4alkyl, C1-C4alkenyl, C1-C4alkynyl, C1-C4alkoxy, amino, aminoC1-C4alkyl, hydroxyC1-C4alkyl, carbonyl, cycloC3-C6alkyl or aminocarbonyl chain are effective as NMDA NR2B antagonists useful for relieving pain.

Abstract: 4-substituted cyclohexanes substituted in the 1-position with quinazoline either directly or through a C1-C4alkyl, C1-C4alkenyl, C1-C4alkynyl, C1-C4alkoxy, amino, aminoC1-C4alkyl, hydroxyC1-C4alkyl, carbonyl, cycloC3-C6alkyl or aminocarbonyl chain are effective as NMDA NR2B antagonists useful for relieving pain.